Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 57086Generated: October 26, 2026

Hydrochloric Acid → 3-chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-amine

https://huagongshe.com/reaction/57086

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantPotassium IodideHCID 4875—
ReactantEthyl BromideHCID 6332—
ReactantIodide IonHCID 30165—
ReactantN-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylacetamideHCID 72194633—
ReactantN-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)acetamideHCID 118023019—
CatalystTetrabutylammonium IodideHCID 67553—
SolventWaterHCID 962—
Product3-chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-amineHCID 118022192—

Reaction Steps

3-Chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-amine (1d) may be prepared through the reaction pathway sequence disclosed in Scheme 3. In step d1, N-(3-chlorol-(pyridin-3-yl)-1H-pyrazol-4-yl)acetamide (1c) may be alkylated with ethyl bromide (EtBr) in the presence of a base, such as sodium hydride (NaH), sodium tert-butoxide (NaOt-Bu), potassium tert-butoxide (KOt-Bu), or sodium tert-amyloxide, in a polar aprotic solvent, such as tetrahydrofuran, at temperatures from about 20° C. to about 40° C., over a period of time of about 60 hours to about 168 hours, to yield N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylacetamide (1c′). It has been discovered that use of an iodide additive, such as potassium iodide (KI) or tetrabutylammonium iodide (TBAI) can decrease the time necessary for the reaction to occur to about 24 hours. It has also been discovered that heating the reaction at about 50° C. to about 70° C. in a sealed reactor (to prevent loss of ethyl bromide) also decreases the reaction time to about 24 hours. In step d2, N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylacetamide (1c′) may be treated with hydrochloric acid in water at temperatures from about 50° C. to about 90° C., to yield 3-chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-amine (1d). The reaction pathway sequence disclosed in Scheme 3 may also be performed without the isolation of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylacetamide (1c′).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09434712B2
Source datasetuspto-grants-2016_09
ORD IDord-1b545da8c99e48168a5e6e8338644669
Source noteuspto-grants-2016_09